Radionetics Oncology (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- January 05, 2024
- Vertical
- Healthcare
- Funding URL
- View Funding Page
- Funding Amount:
- $52,200,000
Company Info
- Founders
- Paul Grayson
- Company Description
- Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.
- Market
- Oncology
- Location
- Menlo Park, California, USA
- Coinvestors
- 5AM Ventures, Crinetics Pharmaceuticals, DCVC Bio, Frazier Life Sciences, GordonMD Global Investments